Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
11.75x1.06x0.33x1.83x7.29x9.64x2.06% 6.91B
19.24x2.26x-3.6x4.42x13.16x13.72x0.52% 77.53B
29.63x4.17x2.6x5.91x17.07x21.46x0.54% 60.78B
37.4x7.64x0.69x12.59x23.04x27.39x-.--% 48.37B
35.1x2.45x-0.64x3.56x10.28x11.67x2.99% 47.28B
14.8x1.3x0.39x2.85x8.61x9.28x-.--% 26.26B
-7.31x3.3x17.45x8.17x-6.26x-5.84x-.--% 20.96B
15.81x2.91x-4.37x2.56x8.16x7.64x-.--% 19.44B
24.45x3.42x0.02x4.95x13.5x17.8x-.--% 15.48B
-40.03x-6.41x0.83x18x-50.22x-59.37x-.--% 15.11B
70.83x28.05x0.81x36.43x49.5x50.44x0.1% 12.85B
12.91x - 0.09x3.07x13.37x24.44x-.--% 10.67B
-210x59.4x2.76x9.4x218.15x-216.23x-.--% 9.42B
34.58x - 2.45x - - - -.--% 7.95B
172.08x6.24x-3.07x - - - - 7.8B
-216.15x - 0.66x - - - -.--% 7.25B
34.38x - 0.43x8.89x26.62x32.78x0.28% 5.61B
-12.14x1.21x0.05x2.33x-22.39x-22.83x0.46% 5.58B
20.21x1.08x1.21x - - - 1.59% 5.44B
Average 2.50x 7.87x 1.01x 8.33x 21.99x -5.20x 0.47% 21.62B
Weighted average by Cap. 15.86x 5.32x 0.57x 7.29x 16.40x 7.56x 0.6%
Biopharmaceuticals